A 2026 study published in the Journal of Clinical Endocrinology & Metabolism found that taking two tablespoons of GlycoShield before meals may reduce post-meal blood sugar spikes and aid weight loss, according to the research team led by Dr. Anna Nowak and Dr. Tomasz Kowalski from the University of Warsaw.
Study Details and Results
The randomized controlled trial involving 120 participants over 12 weeks reported that GlycoShield, a supplement containing cinnamon extract and chromium, reduced postprandial glucose levels by 15% on average. Participants also experienced an average weight loss of 2.3 kilograms, according to the study’s findings. The researchers noted that the effects were most pronounced in individuals with prediabetes.
Dr. Nowak stated, “Our data suggest that GlycoShield may help regulate glycemic response when taken prior to meals, but further research is needed to confirm long-term efficacy and safety.” The study was funded by the Polish National Science Centre and registered with the European Medicines Agency.
Product Availability and Recommendations
NutriHealth, the company marketing GlycoShield, announced in a May 2026 press release that the product is now available in the European Union and United States. A spokesperson for the company said, “GlycoShield is formulated to support metabolic health and complement dietary changes. As with any supplement, we recommend consulting a healthcare provider before use.”
The product’s label includes a disclaimer: “This product is not intended to diagnose, treat, cure, or prevent any disease.” The U.S. Food and Drug Administration (FDA) has not evaluated GlycoShield for medical claims, and the European Food Safety Authority (EFSA) has not approved it as a therapeutic agent.
Expert Caution and Next Steps
While the study’s results are promising, endocrinologists caution that dietary supplements should not replace established treatments for diabetes or obesity. Dr. Maria Szymanska, a metabolic disorders specialist at the Medical University of Warsaw, noted, “Cinnamon and chromium have shown some metabolic benefits in isolated studies, but the combination in GlycoShield requires more rigorous testing. Patients should not rely on it as a substitute for medication or lifestyle interventions.”
The study’s authors plan to conduct a larger trial in 2027 to assess long-term outcomes. Meanwhile, the Polish Ministry of Health has issued a public advisory urging individuals with blood sugar concerns to follow guidelines from their physicians rather than self-medicating with supplements.
Why It Matters
This development highlights the growing interest in natural interventions for metabolic health. However, it also underscores the gap between preliminary research and clinical application. Regulatory bodies continue to emphasize the importance of evidence-based treatments, while consumers seek alternatives to conventional therapies.
Further research is needed to determine whether GlycoShield’s effects are consistent across diverse populations and how it interacts with existing medications. For now, health professionals advise caution and consultation with medical experts before incorporating such supplements into a care plan.
Find more reporting in our Health section.
